Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040945 | SCV000064636 | uncertain significance | not specified | 2018-11-05 | criteria provided, single submitter | clinical testing | The p.Asn3234Ser variant in TTN has been identified by our laboratory in 1 indi vidual with DCM. It has also been identified in 7/282532 chromosomes by gnomAD ( http://gnomad.broadinstitute.org). Computational prediction tools and conservati on analysis suggest that this variant may impact the protein, though this inform ation is not predictive enough to determine pathogenicity. In addition, this var iant is located in the last three bases of the exon, which is part of the 5? spl ice region. Computational tools do not suggest an impact to splicing. In summary , the clinical significance of the p.Asn3234Ser variant is uncertain. ACMG/AMP C riteria applied: PP3. |
Ambry Genetics | RCV002371854 | SCV002690771 | likely benign | Cardiovascular phenotype | 2020-05-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |